Mutations of NT5C2 have been demonstrated to be associated with tumor cell metastasis, proliferation and chemotherapy resistance.[17,18] Meanwhile, GC patients with metastases usually had a poor prognosis. The gene discussed is NT5C2; the disease is neoplasm.